Episode 213: Arun Ananth and Tom Gallo - Data As An Asset With Proscia’s Diagnostic Network

Today my guests are Arun Ananth, CCO and Tom Gallo, CFO from Proscia. What we discuss with Arun and Tom: Introduction to Proscia’s Diagnostic Network Reshaping the economics of pathology Economic opportunities in digital pathology Data as an asset in biomarker discovery Clinical trials as use cases Compliance and security in digital pathology Pathology's central role in treatment Accelerating digital adoption and ROI Patient benefits and clinical trials Risks and barriers in digital pathology Advice for labs considering digital pathology Market adoption and future vision Links for this episode: The Path to PathA Pathologists' Assistant Shadowing Network Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Proscia Cements Leadership in Diagnostic Pathology with 400% Growth in Daily Cases Rewiring the Laboratory’s Bottom Line: Moving Towards Digital Pathology as a Profit Center   People of Pathology Podcast: Twitter Instagram